Financhill
Sell
46

IOSP Quote, Financials, Valuation and Earnings

Last price:
$80.85
Seasonality move :
4.29%
Day range:
$80.07 - $81.97
52-week range:
$70.10 - $116.95
Dividend yield:
2.12%
P/E ratio:
98.17x
P/S ratio:
1.13x
P/B ratio:
1.54x
Volume:
96.6K
Avg. volume:
206.2K
1-year change:
-29.99%
Market cap:
$2B
Revenue:
$1.8B
EPS (TTM):
-$0.06

Analysts' Opinion

  • Consensus Rating
    Innospec, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $99.33, Innospec, Inc. has an estimated upside of 22.89% from its current price of $80.83.
  • Price Target Downside
    According to analysts, the lowest downside price target is $93.00 representing 100% downside risk from its current price of $80.83.

Fair Value

  • According to the consensus of 2 analysts, Innospec, Inc. has 22.89% upside to fair value with a price target of $99.33 per share.

IOSP vs. S&P 500

  • Over the past 5 trading days, Innospec, Inc. has underperformed the S&P 500 by -0.95% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Innospec, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Innospec, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Innospec, Inc. reported revenues of $441.9M.

Earnings Growth

  • Innospec, Inc. earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Innospec, Inc. reported earnings per share of $0.52.
Enterprise value:
1.8B
EV / Invested capital:
--
Price / LTM sales:
1.13x
EV / EBIT:
11.79x
EV / Revenue:
1.00x
PEG ratio (5yr expected):
1.39x
EV / Free cash flow:
64.98x
Price / Operating cash flow:
73.48x
Enterprise value / EBITDA:
8.87x
Gross Profit (TTM):
$501.2M
Return On Assets:
-0.07%
Net Income Margin (TTM):
-0.07%
Return On Equity:
-0.1%
Return On Invested Capital:
-0.09%
Operating Margin:
7.04%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $2B $1.9B $1.8B $443.4M $441.9M
Gross Profit $587M $562.4M $501.2M $124.1M $116.7M
Operating Income $164M $184.5M $151.6M $46.2M $31.1M
EBITDA $207.2M $227.3M $201.5M $57.3M $43.3M
Diluted EPS $5.08 $5.74 -$0.06 $1.33 $0.52
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $683M $846.4M $863.7M $965.6M $988.8M
Total Assets $1.5B $1.7B $1.6B $1.8B $1.8B
Current Liabilities $308.3M $381.4M $344.2M $373.1M $356.1M
Total Liabilities $499.3M $577.3M $490.5M $550.1M $496.5M
Total Equity $993.1M $1.1B $1.1B $1.2B $1.3B
Total Debt $20.2M $32.1M $29.4M $31.7M $33M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $211.9M $230.9M $102.6M $73.5M $39.3M
Cash From Investing -$70.9M -$95.8M -$74.8M -$10.8M -$24.4M
Cash From Financing -$34.4M -$39M -$62.8M -- -$10.6M
Free Cash Flow $140.7M $168.2M $27.5M $61.7M $17.2M
IOSP
Sector
Market Cap
$2B
$26.3M
Price % of 52-Week High
69.12%
81.12%
Dividend Yield
2.12%
0%
Shareholder Yield
3.26%
-2.82%
1-Year Price Total Return
-29.99%
23.08%
Beta (5-Year)
0.910
0.597
Dividend yield:
2.12%
Annualized payout:
$1.55
Payout ratio:
--
Growth streak:
11 years

Technicals

8-day SMA
Buy
Level $80.71
200-day SMA
Sell
Level $81.81
Bollinger Bands (100)
Buy
Level 73.87 - 81.23
Chaikin Money Flow
Sell
Level -19.5K
20-day SMA
Buy
Level $79.47
Relative Strength Index (RSI14)
Buy
Level 58.08
ADX Line
Sell
Level 7.14
Williams %R
Neutral
Level -26.2995
50-day SMA
Buy
Level $76.89
MACD (12, 26)
Buy
Level 6.45
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Sell
Level -96.6K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (5.8186)
Buy
CA Score (Annual)
Level (1.2805)
Buy
Beneish M-Score (Annual)
Level (-2.9266)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.0601)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Innospec, Inc. engages in the development, manufacture, blend, marketing, and supply of fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels. The Performance Chemicals segment provides technology-based solutions for customers processes or products focused on the personal care, home care, agrochemical, and mining industries. The Oilfield Services segment refers to the development and marketing of chemical solutions for fracturing, drilling, stimulation, completion operations, products for oil and gas production, and transport. The company was founded in 1938 and is headquartered in Englewood, CO.

Stock Forecast FAQ

In the current month, IOSP has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IOSP average analyst price target in the past 3 months is $99.33.

  • Where Will Innospec, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Innospec, Inc. share price will rise to $99.33 per share over the next 12 months.

  • What Do Analysts Say About Innospec, Inc.?

    Analysts are divided on their view about Innospec, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Innospec, Inc. is a Sell and believe this share price will drop from its current level to $93.00.

  • What Is Innospec, Inc.'s Price Target?

    The price target for Innospec, Inc. over the next 1-year time period is forecast to be $99.33 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is IOSP A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Innospec, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of IOSP?

    You can purchase shares of Innospec, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Innospec, Inc. shares.

  • What Is The Innospec, Inc. Share Price Today?

    Innospec, Inc. was last trading at $80.85 per share. This represents the most recent stock quote for Innospec, Inc.. Yesterday, Innospec, Inc. closed at $80.83 per share.

  • How To Buy Innospec, Inc. Stock Online?

    In order to purchase Innospec, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock Going to Crash?
Is Palantir Stock Going to Crash?

AI and data analytics major Palantir (NASDAQ:PLTR) has become something…

Why Did AMD Stock Go Up?
Why Did AMD Stock Go Up?

Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…

Will Data Centers Be In Space?
Will Data Centers Be In Space?

With demand for data centers seemingly growing by the day,…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
47
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
56
INTC alert for Jan 24

Intel Corp. [INTC] is down 17.01% over the past day.

Buy
64
BNR alert for Jan 24

Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.

Sell
19
APGE alert for Jan 24

Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock